Katjana Schwab

567 total citations
23 papers, 285 citations indexed

About

Katjana Schwab is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Katjana Schwab has authored 23 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Katjana Schwab's work include Brain Metastases and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Epigenetics and DNA Methylation (4 papers). Katjana Schwab is often cited by papers focused on Brain Metastases and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Epigenetics and DNA Methylation (4 papers). Katjana Schwab collaborates with scholars based in Germany, United States and France. Katjana Schwab's co-authors include Peter Brossart, Annkristin Heine, Glen Kristiansen, Martin Fischer, Konstantin Riege, Steve Hoffmann, Jennifer Landsberg, Alexander Isaak, Narine Mesropyan and Hans H. Schild and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Blood.

In The Last Decade

Katjana Schwab

22 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katjana Schwab Germany 12 142 74 53 44 38 23 285
Ioannis P. Trontzas Greece 11 153 1.1× 97 1.3× 88 1.7× 19 0.4× 12 0.3× 32 338
Takuto Miyagishima Japan 10 126 0.9× 60 0.8× 66 1.2× 42 1.0× 66 1.7× 50 304
Michael J. Buege United States 9 76 0.5× 74 1.0× 43 0.8× 34 0.8× 30 0.8× 15 225
Ayad Al-Katib United States 9 95 0.7× 59 0.8× 21 0.4× 56 1.3× 24 0.6× 17 317
Muhammad Ashar Ali United States 9 73 0.5× 63 0.9× 21 0.4× 53 1.2× 55 1.4× 41 298
Jie Zi China 10 39 0.3× 100 1.4× 45 0.8× 24 0.5× 65 1.7× 32 256
Sumita Saluja India 8 59 0.4× 81 1.1× 26 0.5× 32 0.7× 98 2.6× 22 323
Guangyu Sun China 8 64 0.5× 54 0.7× 60 1.1× 20 0.5× 61 1.6× 39 213
Rafiye Çiftçiler Türkiye 9 61 0.4× 68 0.9× 26 0.5× 49 1.1× 148 3.9× 56 268
Ana Rodrigues Portugal 8 76 0.5× 74 1.0× 66 1.2× 9 0.2× 14 0.4× 33 226

Countries citing papers authored by Katjana Schwab

Since Specialization
Citations

This map shows the geographic impact of Katjana Schwab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katjana Schwab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katjana Schwab more than expected).

Fields of papers citing papers by Katjana Schwab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katjana Schwab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katjana Schwab. The network helps show where Katjana Schwab may publish in the future.

Co-authorship network of co-authors of Katjana Schwab

This figure shows the co-authorship network connecting the top 25 collaborators of Katjana Schwab. A scholar is included among the top collaborators of Katjana Schwab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katjana Schwab. Katjana Schwab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sib, Esther, L. Dias, Bernd Neumann, et al.. (2025). Multicenter exploration of microbial communities in hospital toilets reveals: antibiotic exposure in nosocomial settings selects for Enterococcus over commensal taxa. Antimicrobial Resistance and Infection Control. 14(1). 78–78.
2.
Fischer, Martin, et al.. (2025). p53 reveals principles of chromatin remodeling and enhancer activation. Nucleic Acids Research. 53(11). 1 indexed citations
3.
Schwab, Katjana, Konstantin Riege, Alena van Bömmel, et al.. (2025). Gene regulation by convergent promoters. Nature Genetics. 57(1). 206–217. 3 indexed citations
4.
Schwab, Katjana, et al.. (2024). p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes. Cell Death Discovery. 10(1). 376–376. 4 indexed citations
5.
Sib, Esther, Oliver Schwengers, Katjana Schwab, et al.. (2023). Hospital sanitary facilities on wards with high antibiotic exposure play an important role in maintaining a reservoir of resistant pathogens, even over many years. Antimicrobial Resistance and Infection Control. 12(1). 14 indexed citations
6.
Schwab, Katjana, Konstantin Riege, Erika Kelmer Sacramento, et al.. (2023). Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes. Cell Death Discovery. 9(1). 80–80. 6 indexed citations
7.
Holderried, Tobias A.W., et al.. (2023). Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU). Hematology. 28(1). 2256198–2256198. 1 indexed citations
8.
Faron, Anton, Alexander Isaak, Narine Mesropyan, et al.. (2021). Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study. Radiology. 301(3). 602–609. 39 indexed citations
9.
Riege, Konstantin, Katjana Schwab, Stephan Wolf, et al.. (2021). Transcription factor RFX7 governs a tumor suppressor network in response to p53 and stress. Nucleic Acids Research. 49(13). 7437–7456. 24 indexed citations
10.
Schneider, Matthias, Niklas Schäfer, Christian Bode, et al.. (2021). Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases. Journal of Clinical Medicine. 10(4). 634–634. 12 indexed citations
11.
Schneider, Matthias, Niklas Schäfer, Christian Bode, et al.. (2021). The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival. Journal of Clinical Medicine. 10(17). 4013–4013. 1 indexed citations
12.
Schuss, Patrick, Niklas Schäfer, Christian Bode, et al.. (2021). The Impact of Prolonged Mechanical Ventilation on Overall Survival in Patients With Surgically Treated Brain Metastases. Frontiers in Oncology. 11. 658949–658949. 9 indexed citations
13.
Schwab, Katjana, et al.. (2021). p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance. Oncogene. 41(7). 1063–1069. 23 indexed citations
14.
Heimann, Muriel, Niklas Schäfer, Christian Bode, et al.. (2021). Outcome of Elderly Patients With Surgically Treated Brain Metastases. Frontiers in Oncology. 11. 713965–713965. 14 indexed citations
15.
Schneider, Matthias, Muriel Heimann, Christina Schaub, et al.. (2020). Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain Metastases. Cancers. 12(11). 3209–3209. 20 indexed citations
16.
17.
Schwab, Katjana, et al.. (2018). Successful Treatment of Refractory Squamous Cell Cancer of the Head and Neck with Nivolumab and Ipilimumab. Case Reports in Oncology. 11(1). 17–20. 18 indexed citations
18.
Schwab, Katjana, et al.. (2016). Development of Hemolytic Anemia in a Nivolumab-Treated Patient with Refractory Metastatic Squamous Cell Skin Cancer and Chronic Lymphatic Leukemia. Case Reports in Oncology. 9(2). 373–378. 41 indexed citations
19.
Hahn‐Ast, Corinna, Karin Mayer, Markus Ruhnke, et al.. (2016). Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia. Annals of Hematology. 95(6). 1001–1009. 6 indexed citations
20.
Schwab, Katjana, Corinna Hahn‐Ast, Werner Heinz, et al.. (2013). Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals. Infection. 42(1). 97–104. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis P. Trontzas Breakdown of academic impact, for papers by Takuto Miyagishima Breakdown of academic impact, for papers by Michael J. Buege Breakdown of academic impact, for papers by Ayad Al-Katib Breakdown of academic impact, for papers by Muhammad Ashar Ali Breakdown of academic impact, for papers by Jie Zi Breakdown of academic impact, for papers by Sumita Saluja Breakdown of academic impact, for papers by Guangyu Sun Breakdown of academic impact, for papers by Rafiye Çiftçiler Breakdown of academic impact, for papers by Ana Rodrigues
Rankless by CCL
2026